Fresh, sourced stories worth posting about for venture capitalists — updated every few hours, with the receipts attached. Not generated guesses.
Your desk is ready
Free to start · no card required · your pick is waiting on the other side.
Niche's weekly rollup — one email, no spam.
The stories refresh every few hours from live news and primary sources. Each carries the publisher and the date it was published — so you can see exactly how current it is.
Real reporting and primary filings — every story links its sources. Nothing here is a generated guess; the angle is identified and the receipts are attached.
Yes. These are starting points for your own posts. Draft one and Niche writes it in your voice, platform-native, ready to publish.
Founder-facing explainers on SAFEs, liquidation preferences, participating preferred shares, PAB structures, preferred stock terms, priced rounds, and cap table reading. These signals focus on how financing terms affect dilution and acquisition outcomes for startups.
Draft a post from this →Signals about venture fund operations, including capital calls, distributions, management fees, carry, LP elections, NAV financing, and drawdown mechanics. These pieces cluster around how VC funds manage LP cash flow and waterfall economics.
Draft a post from this →A mix of NIH funding awards and clinical trial recruiting updates for startups and research-driven companies in therapeutics, devices, and digital health-adjacent areas. This cluster captures early validation and de-risking signals that matter to biotech VCs.
Draft a post from this →High-level guides explaining how venture capital works from startup investment to investor returns, alongside investor-side term sheet primers and acquisition anatomy. This is a broader educational cluster on the VC deal lifecycle.
Draft a post from this →A UK-focused outlook on venture capital investment, liquidity, and exit trends. This stands alone as a market-macro narrative rather than a term-level financing explainer.
Draft a post from this →